Report Content
Chapter 1 Methodology
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Electrophysiology industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Indication trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Electrophysiology Industry Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of atrial fibrillation
3.2.1.2 Technological advancements in electrophysiology devices
3.2.1.3 Increasing preference for electrophysiology catheter ablation
3.2.2 Industry pitfalls & challenges
3.2.2.1 High investment for EP devices
3.2.2.2 Dearth of skilled professionals in emerging nations
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By indication
3.3.3 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.5.3 China
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape
4.1 Introduction
4.1.1 Johnson & Johnson
4.1.2 Abbott Laboratories
4.1.3 Siemens Healthineers AG
4.1.4 Koninklijke Philips N.V.
4.2 Company matrix analysis, 2021
4.3 Strategy dashboard, 2021
Chapter 5 Electrophysiology Market, By Product
5.1 Key segment trends
5.2 EP ablation catheters
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Radiofrequency (RF)
5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.3 Cryoablation
5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4 Laser
5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.5 Others
5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 EP diagnostic catheters
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Conventional
5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3 Advanced
5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.4 Ultrasound
5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 EP laboratory devices
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 Mapping systems
5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3 Recording systems
5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.4 Others
5.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Electrophysiology Market, By Indication
6.1 Key segment trends
6.2 Atrial fibrillation
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Ventricular tachycardia
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Atrial tachycardia
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Atrial flutter
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 WOLFF-Parkinson-White (WPW) syndrome
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.7 Atrioventricular nodal reentry tachycardia
6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Electrophysiology Market, By End-use
7.1 Key segment trends
7.2 Hospitals
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Catheterizations laboratories/EP laboratories
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Ambulatory surgical centers
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Others
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Electrophysiology Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Russia
8.3.7 Ukraine
8.3.8 Poland
8.3.9 Switzerland
8.3.10 Belgium
8.3.11 Greece
8.3.12 Czech Republic
8.3.13 The Netherlands
8.3.14 Sweden
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Malaysia
8.4.7 Thailand
8.4.8 Indonesia
8.4.9 Singapore
8.4.10 Taiwan
8.4.11 Philippines
8.4.12 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 Kuwait
8.6.4 UAE
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Biotronik SE & Co. KG.
9.3 Boston Scientific Corporation
9.4 GE Healthcare
9.5 Koninklijke Philips N.V
9.6 Medtronic plc.
9.7 Johnson & Johnson (Biosense Webster, Inc.)
9.8 Microport Scientific Corporation
9.9 Siemens Healthineers AG
9.10 Stereotaxis, Inc.
9.11 CardioFocus
9.12 Japan Lifeline
